Iran develops advanced DNA and RNA analysis devices at one-fifth price of US models

An Iranian knowledge-based company has successfully designed and manufactured advanced DNA and RNA extraction and analysis devices, meeting the country’s critical needs in cancer detection, viral diseases, and forensic genetics at just 20% of the cost of American equivalents.

Behnam Karimi, CEO of Denagen Tajhiz, explained that the research team focused on biotechnology equipment, particularly devices handling nucleic acids and proteins.

These instruments perform sensitive genetic “detection” and “amplification” tasks and have received approvals from reference laboratories and the Iranian Medical Equipment Directorate.

Karimi highlighted that while international brands like Bio-Rad dominate the global market, imported devices are often five times more expensive than the domestically produced models.

Beyond cost, Iranian devices provide significant advantages in after-sales service and calibration, overcoming limitations caused by sanctions that can hinder foreign equipment maintenance.

He also emphasized the customization and rapid delivery capabilities of the production line, allowing devices to be tailored to research or medical center needs and delivered within 7 to 10 working days.
This agility not only ensures timely access to critical tools but also strengthens Iran’s self-reliance in advanced molecular diagnostics.